학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 32,484건 | 목록
1~20
Academic Journal
Pisani, Luigi; Algera, Anna Geke; Neto, Ary Serpa; Azevedo, Luciano Cesar; Pham, Tài; Paulus, Frederique; de Abreu, Marcelo Gama; Pelosi, Paolo; Dondorp, Arjen M.; Bellani, Giacomo; Laffey, John G.; Schultz, Marcus J.; Martinez, Amadeu; Leal, Livia; Jorge Pereira, Antonio; de Oliveira Maia, Marcelo; Neto, Josè Aires; Piras, Claudio; Caser, Eliana Bernadete; Moreira, Cora Lavigne; Braga Gusman, Pablo; Dalcomune, Dyanne Moysés; Ribeiro de Carvalho, Alexandre Guilherme; Gondim, Louise Aline Romão; Castelo Branco Reis, Lívia Mariane; da Cunha Ribeiro, Daniel; de Assis Simões, Leonardo; Campos, Rafaela Siqueira; Fernandez Versiani dos Anjos, José Carlos; Bruzzi Carvalho, Frederico; Alves, Rossine Ambrosio; Nunes, Lilian Batista; Réa-Neto, Álvaro; de Oliveira, Mirella Cristine; Tannous, Luana; Cardoso Gomes, Brenno; Rodriguez, Fernando Borges; Abelha, Priscila; Larsson, Anders; Liu, Haitao; Wang, Wei; Zhang, Fan; Liu, Jian; Li, Bin; Liu, Jing L.; Li, Yuan Y.; Oliveira, Bruno S.; Larsson, Niklas; Smith, Roger; PRoVENT-iMiC study investigators; ERICC study investigators; LUNG SAFE study investigators; PRoVENT study investigators
The Lancet Global Health. 10(2):e227-e235
Academic Journal
Amado-Rodríguez, Laura; Rodríguez-Garcia, Raquel; Bellani, Giacomo; Pham, Tài; Fan, Eddy; Madotto, Fabiana; Laffey, John G.; Albaiceta, Guillermo M.; LUNG SAFE Investigators
Journal of Intensive Care. 10(1)
Conference
2025 IEEE 5th International Conference on ICT in Business Industry & Government (ICTBIG) ICT in Business Industry & Government (ICTBIG), 2025 IEEE 5th International Conference on. :1-6 Dec, 2025
Report
A First-in-Human, Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravenous Hydrogen-Oxygen Nanobubbles in Adults
Hernowo, A. T., Widyarti, S., & Aristyani, S. (2024). Evaluating the safety and therapeutic efficacy of intravenous hydrogen nanobubble infusions in a hypercholesterolemic rat model. Berkala Penelitian Hayati, 30(1), 40-47.
Aulanni'am, A., Riawan, W., Dyah Kinasih, W., Sri Widyarti, S., & Olly Indrayani, P. (2025). Uji Toksisitas Gelembung Nano Gasotransmitter. Institut Molekul Indonesia.
Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013 Feb 5;158(3):200-7. doi: 10.7326/0003-4819-158-3-201302050-00583.
Agustin V, Hernowo A. Stability evaluation of oxyhydrogen and hydrogen nanobubbles under thermal and pH stress conditions. Sci Rep. 2025 Dec 22;15(1):44273. doi: 10.1038/s41598-025-27868-z.
Food and Drug Administration, HHS. International Conference on Harmonisation; Guidance on M3(R2) Nonclinical SafetyStudies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals; availability. Notice. Fed Regist. 2010 Jan 21;75(13):3471-2.
Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007 Jun;13(6):688-94. doi: 10.1038/nm1577. Epub 2007 May 7.
Ichihara M, Sobue S, Ito M, Ito M, Hirayama M, Ohno K. Beneficial biological effects and the underlying mechanisms of molecular hydrogen - comprehensive review of 321 original articles. Med Gas Res. 2015 Oct 19;5:12. doi: 10.1186/s13618-015-0035-1. eCollection 2015.
Agarwal A, Ng WJ, Liu Y. Principle and applications of microbubble and nanobubble technology for water treatment. Chemosphere. 2011 Aug;84(9):1175-80. doi: 10.1016/j.chemosphere.2011.05.054.
Szebeni J. Complement activation-related pseudoallergy caused by amphiphilic drug carriers: the role of lipoproteins. Curr Drug Deliv. 2005 Oct;2(4):443-9. doi: 10.2174/156720105774370212.
Szebeni J. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology. 2005 Dec 15;216(2-3):106-21. doi: 10.1016/j.tox.2005.07.023. Epub 2005 Sep 2.
Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47:89-116. doi: 10.1146/annurev.pharmtox.46.120604.141046.
Mattson MP. Hormesis defined. Ageing Res Rev. 2008 Jan;7(1):1-7. doi: 10.1016/j.arr.2007.08.007. Epub 2007 Dec 5.
Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P, Carr B, Redman CW, Harris AL, Dobson PJ, Harrison P, Sargent IL. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine. 2011 Dec;7(6):780-8. doi: 10.1016/j.nano.2011.04.003. Epub 2011 May 4.
Hernowo, A. T., Widyarti, S., & Aristyani, S. (2024). Evaluating the safety and therapeutic efficacy of intravenous hydrogen nanobubble infusions in a hypercholesterolemic rat model. Berkala Penelitian Hayati, 30(1), 40-47.
Aulanni'am, A., Riawan, W., Dyah Kinasih, W., Sri Widyarti, S., & Olly Indrayani, P. (2025). Uji Toksisitas Gelembung Nano Gasotransmitter. Institut Molekul Indonesia.
Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013 Feb 5;158(3):200-7. doi: 10.7326/0003-4819-158-3-201302050-00583.
Agustin V, Hernowo A. Stability evaluation of oxyhydrogen and hydrogen nanobubbles under thermal and pH stress conditions. Sci Rep. 2025 Dec 22;15(1):44273. doi: 10.1038/s41598-025-27868-z.
Food and Drug Administration, HHS. International Conference on Harmonisation; Guidance on M3(R2) Nonclinical Safety
Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007 Jun;13(6):688-94. doi: 10.1038/nm1577. Epub 2007 May 7.
Ichihara M, Sobue S, Ito M, Ito M, Hirayama M, Ohno K. Beneficial biological effects and the underlying mechanisms of molecular hydrogen - comprehensive review of 321 original articles. Med Gas Res. 2015 Oct 19;5:12. doi: 10.1186/s13618-015-0035-1. eCollection 2015.
Agarwal A, Ng WJ, Liu Y. Principle and applications of microbubble and nanobubble technology for water treatment. Chemosphere. 2011 Aug;84(9):1175-80. doi: 10.1016/j.chemosphere.2011.05.054.
Szebeni J. Complement activation-related pseudoallergy caused by amphiphilic drug carriers: the role of lipoproteins. Curr Drug Deliv. 2005 Oct;2(4):443-9. doi: 10.2174/156720105774370212.
Szebeni J. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology. 2005 Dec 15;216(2-3):106-21. doi: 10.1016/j.tox.2005.07.023. Epub 2005 Sep 2.
Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47:89-116. doi: 10.1146/annurev.pharmtox.46.120604.141046.
Mattson MP. Hormesis defined. Ageing Res Rev. 2008 Jan;7(1):1-7. doi: 10.1016/j.arr.2007.08.007. Epub 2007 Dec 5.
Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P, Carr B, Redman CW, Harris AL, Dobson PJ, Harrison P, Sargent IL. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine. 2011 Dec;7(6):780-8. doi: 10.1016/j.nano.2011.04.003. Epub 2011 May 4.
Report
aPCC and Emicizumab Safety Study in Congenital Hemophilia A Patients With Inhibitors (SAFE Study : Safety of aPCC Following Emicizumab Prophylaxis)
Academic Journal
Ahn, Sanghyun; Lee, Joongyub; Min, Seung-Kee; Ha, Jongwon; Min, Sang-il; Kim, Song-Yi; Cho, Min-Ji; Cho, Sungsin; SAFE Study Investigators
Academic Journal
BMJ: British Medical Journal, 2006 Nov . 333(7577), 1044-1046.
Academic Journal
Conference
Litaker, Harry L.; Beaton, Kara H.; Bekdash, Omar S.; Crues, Edwin Z.; Paddock, Eddie J.; Rohde, Barbara A.J.; Reagan, Marcum L.; Van Velson, Christopher M.; Everett, Shonn F.
2025 IEEE Aerospace Conference Aerospace Conference, 2025 IEEE. :1-16 Mar, 2025
Report
Rezoagli, Emanuele, M.D., Massachusetts General Hospital, Harvard Medical School; Ferrari, Michele, M.D., Massachusetts General Hospital, Harvard Medical School; Patel, Sarvagna, B.A., Massachusetts General Hospital, Harvard Medical School; Zapol, Warren M., M.D., Massachusetts General Hospital, Harvard Medical School; Fisher, Daniel, R.R.T., Massachusetts General Hospital, Harvard Medical School; Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School; Mootha, Vamsi, M.D., Massachusetts General Hospital, Harvard Medical School; Harris, Stuart N., M.D., Massachusetts General Hospital, Harvard Medical School; Karaa, Amel, M.D., Massachusetts General Hospital, Harvard Medical School
Physiological and Biochemical Response to Prolonged Exposure to Hypoxic Breathing in Healthy Volunteers
Report
Testing the Efficacy of Safe South Africa: An Intervention to Prevent HIV Risk and Interpersonal Violence Among Adolescent Boys
Academic Journal
Report
Humberside Fire and Rescue Service; Leicestershire Partnership NHS Trust; University of Nottingham; Kent Fire and Rescue Service; James Cook University, Queensland, Australia; Queensland Health
Do Safe and Well Visits Delivered by the Fire and Rescue Service Reduce Falls and Improve Quality of Life Among Older People? A Randomised Controlled Trial
Cockayne S, Fairhurst C, Cunningham-Burley R, Mann J, Stanford-Beale R, Hampton S, Wilkinson S, Adamson J, Crossland S, Drummond A, Hewitt CE, Pighills A, Roberts G, Ronaldson S, Scantlebury A, Torgerson DJ; FIREFLI team. Effectiveness ofSafe and Well Visits in reducing falls and improving quality of life among older people: The FIREFLI RCT. Public Health Res (Southampt). 2025 Sep;13(7):1-62. doi: 10.3310/DJHF6633.
Adamson J, Scantlebury A, Drummond A, Fairhurst C, Cockayne S; Firefli team. Why do common sense trials fail in the UK? Lessons learned from a trial which tested the effectiveness and cost-effectiveness of a community falls prevention programme (the Fireflistudy ). Trials. 2025 Sep 26;26(1):365. doi: 10.1186/s13063-025-09116-x.
Drahota A, Udell JE, Mackenzie H, Pugh MT. Psychological and educational interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2024 Oct 3;10(10):CD013480. doi: 10.1002/14651858.CD013480.pub2.
Cockayne S, Fairhurst C, Cunningham-Burley R, Mann J, Stanford-Beale R, Hampton S, Wilkinson S, Adamson J, Crossland S, Drummond A, Hewitt CE, Pighills A, Roberts G, Ronaldson S, Scantlebury A, Torgerson DJ; FIREFLI team. Effectiveness of
Adamson J, Scantlebury A, Drummond A, Fairhurst C, Cockayne S; Firefli team. Why do common sense trials fail in the UK? Lessons learned from a trial which tested the effectiveness and cost-effectiveness of a community falls prevention programme (the Firefli
Drahota A, Udell JE, Mackenzie H, Pugh MT. Psychological and educational interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2024 Oct 3;10(10):CD013480. doi: 10.1002/14651858.CD013480.pub2.
Report
Post Marketing Surveillance (PMS) Study for Cibinqo Tablet (Abrocitinib) in Patients With Moderate to Severe Atopic Dermatitis (AD) in Korea
Academic Journal
Laffey, J.G.; Bellani, G.; Pham, T.; Fan, E.; Madotto, F.; Bajwa, E.K.; Thompson, B.T.; Brochard, L.; Slutsky, A.S.; Clarkson, K.; Esteban, A.; Nin, N.; Gattinoni, L.; van Haren, F.; Heunks, L.M.; Kurahashi, K.; Laake, J.H.; Larsson, A.; McAuley, D.F.; McNamee, L.; Qiu, H.; Ranieri, M.; Rubenfeld, G.D.; Wrigge, H.; Pesenti, A.; The LUNG SAFE Investigators and the ESICM Trials Group
In: Intensive Care Medicine . (Intensive Care Medicine, 1 December 2016, 42(12):1865-1876)
Academic Journal
Kong, T.-W.; Kim, J.; Son, J.-H.; Chang, S.-J.; Lee, A.J.; Yang, E.J.; Shim, S.-H.; Kim, N.K.; Kim, Y.; Suh, D.H.; Hwang, D.W.; Park, S.J.; Kim, H.S.; Lee, Y.-Y.; Yoo, J.G.; Lee, S.J.
In: Gynecologic Oncology . (Gynecologic Oncology, September 2023, 176:122-129)
Academic Journal
Miller, Ivan W.; Camargo, Carlos A., Jr.; Arias, Sarah A.; Sullivan, Ashley F.; Allen, Michael H.; Goldstein, Amy B.; Manton, Anne P.; Espinola, Janice A.; Jones, Richard; Hasegawa, Kohei; Boudreaux, Edwin D.; ED-SAFE Investigators
Academic Journal
Taher, F.; Hughes, A.P.; Sama, A.A.; Lebl, D.R.; Cammisa, F.P.; Girardi, F.P.; Zeldin, R.; Schneider, R.; Holodny, E.I.; Fantini, G.A.; Nguyen, J.
In: Spine . (Spine, 15 July 2013, 38(16):1386-1392)
검색 결과 제한하기
제한된 항목
[검색어] SAFE Study Investigators
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어